Edition:
United Kingdom

Daiichi Sankyo Co Ltd (4568.T)

4568.T on Tokyo Stock Exchange

4,064JPY
16 Nov 2018
Change (% chg)

¥-91 (-2.19%)
Prev Close
¥4,155
Open
¥4,149
Day's High
¥4,155
Day's Low
¥4,038
Volume
1,796,000
Avg. Vol
1,747,205
52-wk High
¥5,032
52-wk Low
¥2,612

Latest Key Developments (Source: Significant Developments)

Daiichi Sankyo Announces Clinical Research Collaboration With Merck KGaA, Darmstadt, Germany And Pfizer
Thursday, 25 Oct 2018 

Oct 25 (Reuters) - Daiichi Sankyo Co Ltd <4568.T>::DAIICHI SANKYO ANNOUNCES CLINICAL RESEARCH COLLABORATION WITH MERCK KGAA, DARMSTADT, GERMANY AND PFIZER TO EVALUATE FAM- TRASTUZUMAB DERUXTECAN (DS-8201) WITH AVELUMAB AND A DNA DAMAGE RESPONSE INHIBITOR IN PATIENTS WITH HER2 EXPRESSING AND MUTATED SOLID TUMORS.DAIICHI SANKYO CO LTD - ENTERED INTO A CLINICAL TRIAL COLLABORATION AGREEMENT WITH MERCK KGAA, DARMSTADT, GERMANY AND PFIZER, INC.DAIICHI SANKYO - AGREEMENT TO EVALUATE COMBINATION OF FAM- TRASTUZUMAB DERUXTECAN WITH CHECKPOINT INHIBITOR AVELUMAB AND/OR DDR INHIBITOR.  Full Article

FDA Grants Breakthrough Therapy Designation To Daiichi Sankyo's FLT3 Inhibitor Quizartinib
Wednesday, 1 Aug 2018 

Aug 1 (Reuters) - Daiichi Sankyo Company Limited <4568.T>::FDA GRANTS BREAKTHROUGH THERAPY DESIGNATION TO DAIICHI SANKYO'S FLT3 INHIBITOR QUIZARTINIB FOR RELAPSED/REFRACTORY FLT3-ITD AML.  Full Article

IM issues 2nd tranche convertible bonds worth 7.5 bln won
Thursday, 28 Dec 2017 

Dec 28 (Reuters) - IM Co Ltd <101390.KQ> ::Says it completed issuance of 2nd tranche unregistered and unsecured private convertible bonds worth 7.5 billion won .  Full Article

R&I affirms Daiichi Sankyo's rating at "AA" and says negative outlook-R&I
Friday, 1 Dec 2017 

Dec 1 (Reuters) - Daiichi Sankyo Co Ltd <4568.T>:Rating and Investment Information, Inc. (R&I) affirmed the company's rating at "AA"-R&I.Rating outlook negative-R&I.  Full Article

Daiichi Sankyo to merge with unit Asubio Pharma
Thursday, 30 Nov 2017 

Nov 30 (Reuters) - Daiichi Sankyo Co Ltd <4568.T>:Says it will merge with wholly owned unit Asubio Pharma Co., Ltd., effective April 1, 2018 .Says unit will be dissolved after merger .  Full Article

IM to buy IM DIGITAL PHIL for 5.43 bln won
Monday, 27 Nov 2017 

Nov 27 (Reuters) - IM Co Ltd <101390.KQ> ::Says it plans to buy IM DIGITAL PHIL, Inc, a Philippine Auto Focus Module firm, for 5.43 billion won .  Full Article

Daiichi Sankyo to repurchase shares for up to 50 bln yen
Tuesday, 31 Oct 2017 

Oct 31(Reuters) - Daiichi Sankyo Co Ltd <4568.T>:Says it plans to buy back up to 28 million shares, representing 4.2 percent of outstanding, for up to 50 billion yen, during period from Nov. 1 to March 23, 2018.  Full Article

Daiichi Sankyo to buy back up to 50 bln yen of stock
Tuesday, 31 Oct 2017 

Oct 31 (Reuters) - Daiichi Sankyo <4568.T>::Says it will buy back up to 50 billion yen ($442 million) of stock through March 23.  Full Article

Daiichi Sankyo to close Japan research unit Asubio Pharma
Friday, 10 Feb 2017 

Daiichi Sankyo <4568.T>: Says to close Japan research unit Asubio Pharma .Says move aimed at further reorganising its research and development structure.  Full Article